Found: 6
Select item for more details and to access through your institution.
Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation.
- Published in:
- Pediatric Pulmonology, 2023, v. 58, n. 2, p. 602, doi. 10.1002/ppul.26217
- By:
- Publication type:
- Article
The challenged urine bicarbonate excretion test in cystic fibrosis: A comprehensive analysis of urine acid/base parameters.
- Published in:
- Acta Physiologica, 2024, v. 240, n. 11, p. 1, doi. 10.1111/apha.14233
- By:
- Publication type:
- Article
Challenged Urine Bicarbonate Excretion as a Measure of Cystic Fibrosis Transmembrane Conductance Regulator Function in Cystic Fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Serum C-peptide levels and breast cancer risk: Results from the European prospective investigation into cancer and nutrition (EPIC).
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 3, p. 659, doi. 10.1002/ijc.21861
- By:
- Publication type:
- Article
Real‐world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis.
- Published in:
- APMIS, 2024, v. 132, n. 10, p. 728, doi. 10.1111/apm.13453
- By:
- Publication type:
- Article
Close monitoring and early intervention: management principles for cystic fibrosis in Denmark.
- Published in:
- APMIS, 2024, v. 132, n. 4, p. 223, doi. 10.1111/apm.13375
- By:
- Publication type:
- Article